Jean-Francois Morere
Overview
Explore the profile of Jean-Francois Morere including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
980
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al Jarroudi O, Chaabouni H, Ulusakarya A, Almohamad W, Gumus Y, Goldschmidt E, et al.
Clin Case Rep
. 2021 May;
9(4):2162-2167.
PMID: 33936657
Nivolumab is an effective and safe treatment in HCC.
2.
Roupret M, Morere J, Touboul C, Lhomel C, Couraud S, de La Motte Rouge T
Eur J Cancer Care (Engl)
. 2020 Dec;
30(3):e13392.
PMID: 33336542
Objective: To assess awareness of bladder cancer (BCa) in France. Methods: The French nationwide observational survey EDIFICE 6 was conducted online (26 June-28 July 2017) in 12,046 individuals (age, 18-69 ...
3.
de La Motte Rouge T, Touboul C, Lhomel C, Roupret M, Morere J
Gynecol Oncol
. 2020 Nov;
160(1):112-117.
PMID: 33158509
Introduction: A nationwide cervical cancer (CC) screening program was implemented in France in 2018. Asymptomatic women are invited for a cytological test once every 3 years (age, 25-29 years), and...
4.
Al Jarroudi O, Ulusakarya A, Almohamad W, Afqir S, Morere J
Cureus
. 2020 Nov;
12(10):e11150.
PMID: 33133796
The treatment of recurrent hepatocellular carcinoma (HCC) after liver transplantation is difficult due to the lack of effective treatment options. The available evidence on the emerging immunotherapy in liver transplantation...
5.
Simon H, Ganem G, Touboul C, Lhomel C, Morere J
Eur J Cancer Care (Engl)
. 2020 Sep;
29(6):e13299.
PMID: 32885521
Objective: Over recent decades, supportive care and patient quality of life, advocated by dedicated guidelines, have become a core focus of the concept of integrative medicine. The Calista 2 survey...
6.
Komarzynski S, Huang Q, Levi F, Palesh O, Ulusakarya A, Bouchahda M, et al.
Sleep
. 2019 Jul;
42(10).
PMID: 31323086
Subjective sleep assessment in cancer patients poorly correlates with actigraphy parameters that usually encompass multiple nights. We aimed to determine the objective actigraphy measures that best correlated with subjective sleep...
7.
Ulusakarya A, Teyar N, Karaboue A, Haydar M, Krimi S, Biondani P, et al.
Medicine (Baltimore)
. 2019 Apr;
98(16):e15341.
PMID: 31008993
FOLFIRINOX is one of the most effective reference regimens in the 1st line treatment of locally advanced (LA) and metastatic pancreatic cancer (mPC), despite its high toxicity. We evaluated our...
8.
Ruiz A, Sebagh M, Saffroy R, Allard M, Bosselut N, Hardoin G, et al.
BMC Cancer
. 2019 Feb;
19(1):169.
PMID: 30795751
Background: Liver metastases of breast cancer are frequent and can recur even after "complete/R0" resection in combination with systemic and hormonal treatments. The aim of this study was to analyze...
9.
Couraud S, Cortot A, Pivot X, Touboul C, Lhomel C, Blay J, et al.
Prev Med Rep
. 2018 Jun;
10:332-336.
PMID: 29868388
Although e-cigarette use is increasing dramatically, numerous concerns persist regarding toxicity and their role in smoking cessation. We assessed beliefs and behavior regarding e-cigarettes in an adult French population. The...
10.
Viguier J, Morere J, Brignoli-Guibaudet L, Lhomel C, Couraud S, Eisinger F
Curr Oncol Rep
. 2018 Mar;
20(Suppl 1):16.
PMID: 29508157
Background: The aim of EDIFICE surveys is to improve insight into the behavior of the French population with regard to cancer prevention and participation in screening programs. Via the colorectal...